No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model

INTRODUCTION: Donepezil is a widely used cholinesterase inhibitor in the management of Alzheimer's disease. Despite large-scaled evidence for its efficacy, elevated peripheral ACh levels often lead to side effects and are dose limiting. The present exploratory study is designed to determine the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement (N Y)
Main Authors: Baakman, Anne Catrien, Alvarez-Jimenez, Ricardo, Loewen, Gordon, de Kam, Marieke L., Broekhuizen, Karen, Hilt, Dana C., Groeneveld, Geert Jan
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Featured Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6446049/
https://ncbi.nlm.nih.gov/pubmed/30984817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.02.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados